Cargando…
Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
PURPOSE: Prostate biopsy is used to confirm the prostate cancer. Although first biopsy result was benign, repeat biopsy is recommended for the patient who has higher risk of prostate cancer. In this study, we investigated the PSA change ratio (post-biopsy PSA to baseline PSA) whether it could be pre...
Autores principales: | Lee, Jung Gon, Bae, Seong Ho, Choi, Seock Hwan, Kwon, Tae Gyun, Kim, Tae-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406192/ https://www.ncbi.nlm.nih.gov/pubmed/22866217 http://dx.doi.org/10.4111/kju.2012.53.7.467 |
Ejemplares similares
-
Clinical significance of the De Ritis ratio for detecting prostate cancer in a repeat prostate biopsy
por: Ha, Heon, et al.
Publicado: (2019) -
Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
por: Long, Xingbo, et al.
Publicado: (2020) -
Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020) -
Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020) -
Dilemmas Over the Decision to Perform Repeat Prostate Biopsies
por: Hong, Sung Kyu
Publicado: (2014)